Analysts Offer Insights on Healthcare Companies: Crinetics Pharmaceuticals (CRNX), Elevance Health (ELV) and Johnson & Johnson (JNJ)
JPMorgan Raises Price Target on Crinetics Pharmaceuticals to $54 From $47, Maintains Overweight Rating
Crinetics Pharmaceuticals Analyst Ratings
Crinetics Pharmaceuticals Analyst Ratings
Piper Sandler Sticks to Its Buy Rating for Crinetics Pharmaceuticals (CRNX)
Crinetics Pharmaceuticals Analyst Ratings
Crinetics Pharmaceuticals Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Aldeyra Therapeutics (ALDX), LAVA Therapeutics (LVTX) and Crinetics Pharmaceuticals (CRNX)
Analysts Offer Insights on Healthcare Companies: Crinetics Pharmaceuticals (CRNX) and BioMarin Pharmaceutical (BMRN)
Crinetics Pharmaceuticals Analyst Ratings
Analysts Are Bullish on These Healthcare Stocks: Crinetics Pharmaceuticals (CRNX), Lipella Pharmaceuticals, Inc. (LIPO)
Buy Rating Affirmed for Crinetics Pharmaceuticals Amid Promising Atumelnant Data for CAH
Crinetics Pharmaceuticals Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Crinetics Pharmaceuticals (CRNX), Wave Life Sciences (WVE) and Intellia Therapeutics (NTLA)
Oppenheimer Reaffirms Their Buy Rating on Crinetics Pharmaceuticals (CRNX)
Crinetics Pharmaceuticals Analyst Ratings
Buy Rating Affirmed for Crinetics Pharmaceuticals on Strong Drug Pipeline and Market Potential
Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Crinetics Pharmaceuticals (CRNX) and Alignment Healthcare (ALHC)
Analysts Offer Insights on Healthcare Companies: Staar Surgical (STAA), Pliant Therapeutics (PLRX) and Crinetics Pharmaceuticals (CRNX)
Crinetics Pharmaceuticals Analyst Ratings